← Leaderboards
David M Orenstein
Children'S Hosp Pittsburgh/Upmc Hlth Sys
$1,638,279
Attributed
$1,638,279
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $427.9K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,638,279 · 5
By mechanism
R01$1,598,395 · 1
M01$39,884 · 4
Top collaborators
No co-investigators on record.
Most similar at Children'S Hosp Pittsburgh/Upmc Hlth Sys
Same institution · by research overlap
- Glenna Winnie$0
- Cuneyt Metin Alper$5,139,585
- Geoffrey Kurland$0
- Jonathan D Finder$115,425
- Margaretha L Casselbrant$5,198,057
Others in their field
Top investigators on “Cystic Fibrosis”
- John F Engelhardt · University Of Iowa$42,933,706
- Michael R Knowles · University Of North Carolina Chapel Hill$30,250,682
- David A Stoltz · University Of Iowa$25,455,359
- Joseph Zabner · University Of Iowa$25,382,103
- Paul B McCray · University Of Iowa$25,146,293
- Richard C Boucher · University Of North Carolina Chapel Hill$24,890,955
Research focus
Cystic FibrosisEducational StatusCessation Of LifeDeteriorationDiagnosisBaseBehaviorBirthCystic Fibrosis PatientsAreaAnalogAttentionCaucasiansCaucasoid RaceAerobicChildChildren With Cystic FibrosisChronic DiseaseBloodAbbreviationsEnergy MetabolismControl GroupsCarbon DioxideExcision
Grant awards (9)
Self-Regulated Exercise in CF: A Randomized Trial$427,933
R01 · FY2010 · NR · contact PI
Self-Regulated Exercise in CF: A Randomized Trial$408,730
R01 · FY2009 · NR · contact PI
Self-Regulated Exercise in CF: A Randomized Trial$353,051
R01 · FY2008 · NR · contact PI
Self-Regulated Exercise in CF: A Randomized Trial$408,681
R01 · FY2007 · NR · contact PI
PHSE 2 RNDM DBL BLND PARLLEL DSE RNGNG STDY OF ORAL THERACLEC-TTL IN CF SBJCT$28,698
M01 · FY2005 · RR
DIABETES THERAPY TO IMPROVE MUSCLE MASS AND CLINICAL STATUS IN CF SUBJECTS WITH$2,923
M01 · FY2005 · RR
STANDARD VERSUS BIOFILM SUSCEPTIBILITY TESTING IN CF$1,063
M01 · FY2005 · RR
A Phase I, Open-Label Safety and Tolerability Study of Oral Thera CLEC-Total$5,495
M01 · FY2004 · RR
Diabetes Therapy to Improve Muscle Mass and Clinical Status in CF Subjects with$1,705
M01 · FY2004 · RR